Form 8-K - Current report:
SEC Accession No. 0001144204-14-014913
Filing Date
2014-03-11
Accepted
2014-03-11 17:13:19
Documents
1
Period of Report
2014-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v371309_8-k.htm 8-K 14795
  Complete submission text file 0001144204-14-014913.txt   15953
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 14685081
SIC: 2835 In Vitro & In Vivo Diagnostic Substances